Literature DB >> 18366951

Private sector provision and financing of AIDS treatment in Africa: current developments.

Frank Feeley1, Patrick Connelly, Sydney Rosen.   

Abstract

Despite the rapid expansion of public sector highly active antiretroviral (ARV) treatment programs, the private sector continues to be an important source of services and financing for AIDS treatment in Africa. This article reviews currently available information on private sector initiatives, including recent innovations. Private sector providers continue to offer ARV treatment, although adherence problems resulting from high user fees indicate the need for employer, donor, or insurance support. Employer clinics have reported impressive results in patient recruitment and survival. Health insurers are removing AIDS exclusions and expanding AIDS coverage, in some cases with targeted lower cost policies. Public- or donor-funded ARVs have been used to leverage the expansion of populations treated at employer clinics, and attempts are underway to contract for private sector services using public and donor funds. With both funds and clinical resources stretched to meet AIDS treatment goals in countries with a high prevalence of HIV, further efforts are indicated to leverage private sector resources as part of a national treatment plan.

Entities:  

Mesh:

Year:  2007        PMID: 18366951     DOI: 10.1007/s11904-007-0028-3

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  7 in total

1.  Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector.

Authors:  Gregory P Bisson; Ian Frank; Robert Gross; Vincent Lo Re; Jordan B Strom; Xingmei Wang; Mpho Mogorosi; Tendani Gaolathe; Ndwapi Ndwapi; Harvey Friedman; Brian L Strom; Diana Dickinson
Journal:  AIDS       Date:  2006-06-12       Impact factor: 4.177

2.  HAART for the HIV-infected employees of large companies in Africa.

Authors:  Stefaan Van der Borght; Tobias F Rinke de Wit; Vincent Janssens; Maarten F Schim van der Loeff; Henk Rijckborst; Joep M A Lange
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

3.  Treatment of HIV/AIDS at South Africa's largest employers: myth and reality.

Authors:  Patrick Connelly; Sydney Rosen
Journal:  S Afr Med J       Date:  2006-02

4.  Steady growth in antiretroviral treatment provision by disease management and community treatment programmes.

Authors:  Leigh F Johnson; Heather D McLeod
Journal:  S Afr Med J       Date:  2007-05

5.  A successful workplace program for voluntary counseling and testing and treatment of HIV/AIDS at Heineken, Rwanda.

Authors:  Alizanne C Collier; Stefaan F M Van der Borght; Tobias Rinke de Wit; Tobias F Rinke de Wit; Sarah C Richards; Frank G Feeley
Journal:  Int J Occup Environ Health       Date:  2007 Jan-Mar

6.  Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses.

Authors:  Charles Kabugo; Sylver Bahendeka; Raymond Mwebaze; Samuel Malamba; David Katuntu; Robert Downing; Jonathan Mermin; Paul J Weidle
Journal:  J Acquir Immune Defic Syndr       Date:  2005-04-15       Impact factor: 3.731

7.  Establishing a workplace antiretroviral therapy programme in South Africa.

Authors:  S Charalambous; A D Grant; J H Day; L Pemba; R E Chaisson; P Kruger; D Martin; R Wood; B Brink; G J Churchyard
Journal:  AIDS Care       Date:  2007-01
  7 in total
  3 in total

Review 1.  Leveraging the lessons learned from financing HIV programs to advance the universal health coverage (UHC) agenda in the East African Community.

Authors:  Henry Zakumumpa; Sara Bennett; Freddie Ssengooba
Journal:  Glob Health Res Policy       Date:  2019-09-13

2.  Anonymous HIV workplace surveys as an advocacy tool for affordable private health insurance in Namibia.

Authors:  Ingrid de Beer; Hannah M Coutinho; Peter J van Wyk; Esegiel Gaeb; Tobias Rinke de Wit; Michèle van Vugt
Journal:  J Int AIDS Soc       Date:  2009-11-11       Impact factor: 5.396

3.  The case for stronger regulation of private practitioners to control tuberculosis in low- and middle-income countries.

Authors:  Yodi Mahendradhata
Journal:  BMC Res Notes       Date:  2015-10-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.